Elias A. Zerhouni - 27 May 2025 Form 4 Insider Report for OPKO HEALTH, INC. (OPK)

Reporting relationship
Vice Chairman and President, Director
Issuer ticker
OPK
Reported as of
27 May 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 May 2025, 17:05:24 UTC
Prior SEC filing
19 May 2025
Next SEC filing
16 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Steven D. Rubin, Attorney-in-Fact

Key filing fact

Elias A. Zerhouni filed Form 4 for OPKO HEALTH, INC. (OPK) on 29 May 2025.

Key facts

  • This page summarizes Elias A. Zerhouni's Form 4 filing for OPKO HEALTH, INC. (OPK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 29 May 2025, 17:05.

Change

  • Previous filing in this sequence was filed on 19 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001478398 Primary reporting owner

Zerhouni Elias A.

Relationship
Vice Chairman and President, Director
Address
OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI
Signature
Steven D. Rubin, Attorney-in-Fact
Signature date
29 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OPK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+500,000
Change %
Price
$0.000000
Shares after
500,000
Date
27 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000
Exercise price
$1.31
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option will vest in four equal annual installments beginning May 27, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .